Education
About Us
Working with TipRanks
Follow Us
David Pendarvis Insider Profile
4 Followers
David Pendarvis, CAO at Resmed, holds 5.86K shares in WD-40 Company (Ticker: WDFC), holds 89.73K shares in Resmed (Ticker: RMD), holds 112.97K shares in Sequenom (Ticker: SQNM). Most recently, David Pendarvis Bought ― shares of WD-40 Company on Oct 30, 2025 for an estimated value of $102.70K.
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-15.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by David Pendarvis
David Pendarvis's Trading History
Resmed
Jun 07, 2023
CAO
Uninformative Sell
329.69K
$22.57M
WD-40 Company
Oct 30, 2025
Director
Informative Buy
102.70K
$1.16M
Sequenom
Sep 07, 2016
―
Uninformative Sell
―
$270.00K
List of latest transactions for each holding click on a transaction to see David Pendarvis's performance on stock
You May Also Like
David Pendarvis insider profile FAQ
What is the percentage of profitable transactions made by David Pendarvis?
The percentage of profitable transactions made by David Pendarvis is 25%.
What is the average return per transaction made by David Pendarvis?
The average return per transaction made by David Pendarvis is -15.40%.
What stocks does David Pendarvis hold?
David Pendarvis holds: RMD, WDFC, SQNM stocks.
What was David Pendarvis’s latest transaction?
David Pendarvis latest transaction was an Informative Buy of $102.70K.
What was David Pendarvis's most profitable transaction?
David Pendarvis’s most profitable transaction was an Informative Buy of RMD stock on November 16, 2015. The return on the trade was 3.20%.
What is David Pendarvis's role in Resmed?
David Pendarvis's role in Resmed is CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.